The world’s first whole-body portable ultrasound continues its rapid expansion and distribution around the world, while also showing significant clinical utility in fighting the COVID-19 pandemic.
The Butterfly Network’s portable ultrasound is currently used in twenty-one different countries worldwide. For only $2000 USD, the biomedical product has been in demand from countries such as Australia, New Zealand, Canada and Argentina.
Dr John Martin, one of the chief forces behind the Butterfly Network’s portable ultrasound, says “using the device can help stop the spread of COVID-19 within hospitals, and reduce current wait times. This ultrasound is much more sensitive than a CT scan, and requires less cleaning. This means that there are fewer hospital staff put in potentially risky situations, and there may not need to be as many patients needing hospital isolation.”
“We can also track lung involvement with the device, and determine the prospect of a patient developing pneumonia, as the ultrasound is much more sensitive than a regular x-ray,” says Martin.
The ultrasound is small, portable and takes images that can be uploaded to the Cloud. The sharing of data at the present time is incredibly important for the medical community, as COVID-19 cases escalate worldwide.
“With the acceleration in COVID-19, I believe both patients and medical staff understand how beneficial a device such as this can be in saving lives,” says Martin.